Top

Published in:

01-10-2005 | Original Paper

Enhancement of antibacterial superoxide-anion generation in human monocytes by fumaric acid esters

Authors: Kejian Zhu, Ulrich Mrowietz

Published in: Archives of Dermatological Research | Issue 4/2005

Abstract

Fumaric acid esters (FAE) are used for the systemic therapy of psoriasis with high clinical efficacy. Among the potential side effects of FAE therapy, lymphocytopenia is sometimes observed. We have investigated the effect of dimethylfumarate (DMF) and its main metabolite methylhydrogenfumarate (MHF) as well as dexamethasone on superoxide anion generation by human monocytes and neutrophils after stimulation with bacteria (Staphylococcus aureus and Escherichia coli) and the yeast Candida albicans in addition with zymosan particles and with the tripeptide fMLP. Expression of mannose receptors on monocytes and neutrophils was also analyzed. The results showed that dexamethasone significantly inhibited superoxide anion generation from monocytes in response to bacteria and C. albicans, whereas DMF as well as MHF dose dependently increased the production of superoxide anion in monocytes in response to zymosan, fMLP and bacteria. Dexamethasone, DMF or MHF did not modulate superoxide anion generation of neutrophils. Expression of mannose receptors on monocytes was not regulated by DMF or MHF. Our data provide evidence that DMF and MHF do not alter the production of superoxide anions as an important mechanism of innate defense against microorganisms.

Nickoloff BJ (1999) Skin innate immune system in psoriasis: friend or foe? J Clin Invest 104:1161–1164PubMedCrossRef

Walsh SR, Shear NH (2004) Psoriasis and the new biologic agents: interrupting a T-AP dance. CMAJ 170:1933–1941PubMed

McClure SL, Valentine J, Gordon KB (2002) Comparative tolerability of systemic treatments for plaque-type psoriasis. Drug Saf 25:913–927PubMedCrossRef

Krupp P0000, Monka C (1990) Side-effect profile of cyclosporin A in patients treated for psoriasis. Br J Dermatol 122 (Suppl 36):47–56PubMedCrossRef

Sugie N, Fujii N, Danno K (2002) Cyclosporin-A suppresses p53-dependent repair DNA synthesis and apoptosis following ultraviolet-B irradiation. Photodermatol Photoimmunol Photomed 18:163–168CrossRefPubMed

Djaldetti M, Salman H, Bergman M, Djaldetti R, Bessler H (2002) Phagocytosis–the mighty weapon of the silent warriors. Microsc Res Tech 57:421–431CrossRefPubMed

Chen AM, Scott MD (2001) Current and future applications of immunological attenuation via pegylation of cells and tissue. BioDrugs 15:833–847PubMedCrossRef

Klein NC, Go CH, Cunha BA (2001) Infections associated with steroid use. Infect Dis Clin North Am 15:423–432, viii

Zaczynska E, Olszewska ZB (2001) Effect of cyclosporine A on the non-specific, innate antiviral immunity of mice. Arch Immunol Ther Exp (Warsz) 49 (Suppl 1):S53–S57

10.

Chen SY, Liu ST, Hou LB, Chen ZL (1998) Effects of ciclosporin on whole blood chemiluminescence of renal transplant patients. Zhongguo Yao Li Xue Bao 19:372–375PubMed

11.

Roilides E, Robinson T, Sein T, Pizzo PA, Walsh TJ (1994) In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus. Antimicrob Agents Chemother 38:2883–2888PubMed

12.

Bober LA, Grace MJ, Pugliese-Sivo C, Rojas-Triana A, Sullivan LM, Narula SK (1995) The effects of colony stimulating factors on human monocyte cell function. Int J Immunopharmacol 17:385–392CrossRefPubMed

13.

Mrowietz U, Christophers E, Altmeyer P (1997) Treatment of psoriasis with fumaric acid esters. Results of a prospective multicenter study. Br J Dermatol 138:456–460CrossRef

14.

Altmeyer P, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P, Wassilew S, Horn T, Kreysel HW, Lutz G, Barth J, Rietzschel I, Joshi RK (1994) Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 30:977–981PubMed

15.

Mrowietz U, Christophers E (1988) Modulation of human monocyte functions during acute bacterial infection. Scand J Immunol 28:139–146PubMedCrossRef

16.

Mrowietz U, Asadullah K (2005) Dimethylfumarate for psoriasis: more than a dietary curiosity. Trends Mol Med 11:43–48CrossRefPubMed

17.

Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN (2003) Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 149:363–369CrossRefPubMed

18.

Höxtermann S, Nüchel C, Altmeyer P (1998) Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis. Dermatology 196:223–230CrossRefPubMed

19.

Heiligenhaus A, Li H, Wasmuth S, Bauer D (2004) Influence of dimethylfumarate on experimental HSV-1 necrotizing keratitis. Graefes Arch Clin Exp Ophthalmol 242:870–877CrossRefPubMed

20.

Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT (1988) Neutrophils and host defense. Ann Intern Med 109:127–142PubMed

21.

Lasser A (1983) The mononuclear phagocytic system: a review. Hum Pathol 14:108–126PubMed

22.

Davis JM, Gallin JI (1981) The Neutrophils. In: Oppenheim JJ, Rosenstreich D, Potter M (eds) Cellular functions in immunology and inflammation. Elsevier, New York, pp 87–88

23.

Litjens NH, Nibbering PH, Barrois AJ, Zomerdijk TP, Van Den Oudenrijn AC, Noz KC, Rademaker M, Van De Meide PH, Van Dissel JT, Thio B (2003) Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines. Br J Dermatol 148:444–451CrossRefPubMed

24.

Lee SJ, Zheng NY, Clavijo M, Nussenzweig MC (2003) Normal host defense during systemic candidiasis in mannose receptor-deficient mice. Infect Immun 71:437–445CrossRefPubMed

25.

Stahl PD, Ezekowitz RA (1998) The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 10:50–55CrossRefPubMed

26.

Koziel H, Eichbaum Q, Kruskal BA, Pinkston P, Rogers RA, Armstrong MY, Richards FF, Rose RM, Ezekowitz RA (1998) Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest 102:1332–1344PubMed

27.

Marodi L, Schreiber S, Anderson DC, MacDermott RP, Korchak HM, Johnston RB Jr (1993) Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest 91:2596–2601PubMedCrossRef

28.

Noorman F, Braat EA, Barrett-Bergshoeff M, Barbe E, van Leeuwen A, Lindeman J, Rijken DC (1997) Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages. J Leukoc Biol 61:63–72PubMed

29.

Zhu Y, Li X, Schuchman EH, Desnick RJ, Cheng SH (2004) Dexamethasone-mediated up-regulation of the mannose receptor improves the delivery of recombinant glucocerebrosidase to Gaucher macrophages. J Pharmacol Exp Ther 308:705–711CrossRefPubMed

30.

Woltman AM, Schlagwein N, van der Kooij SW, van Kooten C (2004) The novel cyclophilin-binding drug sanglifehrin A specifically affects antigen uptake receptor expression and endocytic capacity of human dendritic cells. J Immunol 172:6482–6489PubMed

31.

Peters-Golden M, Thebert P (1987) Inhibition by methylprednisolone of zymosan-induced leukotriene synthesis in alveolar macrophages. Am Rev Respir Dis 135:1020–1026PubMed

32.

Webb DS, Roth JA (1987) Relationship of glucocorticoid suppression of arachidonic acid metabolism to alteration of neutrophil function. J Leukoc Biol 41:156–164PubMed

33.

Haugen SE, Wiik P (1997) Glucocorticoid and ACTH regulation of rat peritoneal phagocyte chemiluminescence and nitric oxide production in culture. Acta Physiol Scand 161:93–101CrossRefPubMed

34.

Becker J, Grasso RJ (1985) Suppression of phagocytosis by dexamethasone in macrophage cultures: inability of arachidonic acid, indomethacin, and nordihydroguaiaretic acid to reverse the inhibitory response mediated by a steroid-inducible factor. Int J Immunopharmacol 7:839–847CrossRefPubMed

35.

van der GA, Hoekstra K, van den Berg TK, Dijkstra CD (2000) Dexamethasone promotes phagocytosis and bacterial killing by human monocytes/macrophages in vitro. J Leukoc Biol 67:801–807PubMed

36.

Heidenreich S, Kubis T, Schmidt M, Fegeler W (1994) Glucocorticoid-induced alterations of monocyte defense mechanisms against Candida albicans. Cell Immunol 157:320–327CrossRefPubMed

37.

Keil D, Luebke RW, Pruett SB (2001) Quantifying the relationship between multiple immunological parameters and host resistance: probing the limits of reductionism. J Immunol 167:4543–4552PubMed

38.

Barton AE, Bayley DL, Mikami M, Llewellyn-Jones CG, Stockley RA (2000) Phenotypic changes in neutrophils related to anti-inflammatory therapy. Biochim Biophys Acta 1500:108–118PubMed

39.

Buyon JP, Korchak HM, Rutherford LE, Ganguly M, Weissmann G (1984) Female hormones reduce neutrophil responsiveness in vitro. Arthritis Rheum 27:623–630PubMedCrossRef

40.

Nesher G, Moore TL, Dorner RW (1991) In vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine. Ann Rheum Dis 50:637–641PubMed

Title: Enhancement of antibacterial superoxide-anion generation in human monocytes by fumaric acid esters
Authors: Kejian Zhu
Ulrich Mrowietz
Publication date: 01-10-2005
Publisher: Springer-Verlag
Published in: Archives of Dermatological Research / Issue 4/2005
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-005-0598-0

At a glance: The STEP trials

Springer Medicine

Enhancement of antibacterial superoxide-anion generation in human monocytes by fumaric acid esters

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2005

Disulphide reaction staining for the identification of integumental elastic fibres

Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma

Upregulation of transforming growth factor-β1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity

Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin

Anti-DNA topoisomerase II α autoantibodies in Japanese patients with systemic sclerosis

Patients with a large prostate show a higher prevalence of androgenetic alopecia